These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6779312)

  • 1. Effects of d-amphetamine and naloxone on brain stimulation reward.
    Esposito RU; Perry W; Kornetsky C
    Psychopharmacology (Berl); 1980; 69(2):187-91. PubMed ID: 6779312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat.
    Holtzman SG
    Psychopharmacologia; 1976 Apr; 46(3):223-7. PubMed ID: 951457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effects of morphine and d-amphetamine on the threshold for brain stimulation reward.
    Hubner CB; Bain GT; Kornetsky C
    Pharmacol Biochem Behav; 1987 Oct; 28(2):311-5. PubMed ID: 3685064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and interactions of naloxone and amphetamine on self-stimulation of the prefrontal cortex and dorsal tegmentum.
    Franklin KB; Robertson A
    Pharmacol Biochem Behav; 1982 Mar; 16(3):433-6. PubMed ID: 7079280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of morphine analgesia by d-amphetamine.
    Sasson S; Unterwald EM; Kornetsky C
    Psychopharmacology (Berl); 1986; 90(2):163-5. PubMed ID: 3097695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of morphine, naloxone, d,l-cyclazocine, and d-amphetamine on behaviour controlled by a schedule of interresponse time reinforcement.
    Adam-Carrière D; Merali Z; Stretch R
    Can J Physiol Pharmacol; 1978 Oct; 56(5):707-20. PubMed ID: 709412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A progressive ratio schedule of self-stimulation testing in rats reveals profound augmentation of d-amphetamine reward by food restriction but no effect of a "sensitizing" regimen of d-amphetamine.
    Cabeza de Vaca S; Krahne LL; Carr KD
    Psychopharmacology (Berl); 2004 Aug; 175(1):106-13. PubMed ID: 14985931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1990; 102(2):263-8. PubMed ID: 2274609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects.
    Borowski TB; Kokkinidis L
    Pharmacol Biochem Behav; 1992 Sep; 43(1):1-15. PubMed ID: 1409792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions and interactions of amphetamine on self-stimulation in rats.
    Aulakh CS; Pradhan SN
    Pharmacol Biochem Behav; 1979 Sep; 11(3):351-4. PubMed ID: 41267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine withdrawal: effects on threshold of intracranial reinforcement.
    Cassens G; Actor C; Kling M; Schildkraut JJ
    Psychopharmacology (Berl); 1981; 73(4):318-22. PubMed ID: 6789351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcement.
    Andrews JS; Holtzman SG
    Pharmacol Biochem Behav; 1987 Jan; 26(1):167-71. PubMed ID: 3562487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
    Andrews JS; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-butyrolactone's discriminability and effect on low rates of lever pressing by rats: alone and in combination with D-amphetamine and naloxone.
    McIntire KD; Cleary J; Weinfurter S
    Pharmacol Biochem Behav; 1988 May; 30(1):45-53. PubMed ID: 3174754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of separate and combined administration of naloxone and d-amphetamine.
    Holtzman SG
    J Pharmacol Exp Ther; 1974 Apr; 189(1):51-60. PubMed ID: 4823299
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.
    Mavrikaki M; Nomikos GG; Panagis G
    Int J Neuropsychopharmacol; 2010 May; 13(4):541-8. PubMed ID: 20047715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of central leptin infusion on the reward-potentiating effect of D-amphetamine.
    Hao J; Cabeza de Vaca S; Pan Y; Carr KD
    Brain Res; 2006 May; 1087(1):123-33. PubMed ID: 16600190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Amphetamine-induced hypothermia and hypermotility in rats: changes after systemic administration of beta-endorphin.
    Yehuda S; Zadina J; Kastin AJ; Coy DH
    Peptides; 1980; 1(2):179-85. PubMed ID: 7243618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of d-amphetamine, pipradrol and bupropion on shuttlebox self-stimulation.
    Liebman JM; Gerhardt S; Prowse J
    Pharmacol Biochem Behav; 1982 May; 16(5):791-4. PubMed ID: 6124009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.